Fig. 7.
Fig. 7. Cb2 expression and function in normal spleen and thymus. / (A) RNase protection on 10 μg total mouse mRNA isolated from several organs. The protected fragments were 249 nucleotides (exon-1B/exon-2Cb2 mRNA-protected) or 148 nucleotides (exon-2Cb2 mRNA-protected, representing exon-1A/exon-2). AGAPDH probe was used for normalization of the signals. (B) Receptor density (femtomoles per 106 cells) on spleen cells and thymocytes was assessed by measuring specific binding of [3H]CP55940 (1 nM) (see “Materials and methods”). (C) Effect of Cb1-specific antagonist SR141716 or Cb2-specific antagonist SR144528 on spontaneous or 2-AG–induced migration of spleen cells. Antagonists and 2-AG were placed in the wells as indicated under the figure.Y-axis shows percentage of migration from an input of 2 × 105 spleen cells. (D) Immunophenotyping of 2-AG–induced migrated spleen cells versus spontaneous spleen-migrated cells using flow cytometry.

Cb2 expression and function in normal spleen and thymus.

(A) RNase protection on 10 μg total mouse mRNA isolated from several organs. The protected fragments were 249 nucleotides (exon-1B/exon-2Cb2 mRNA-protected) or 148 nucleotides (exon-2Cb2 mRNA-protected, representing exon-1A/exon-2). AGAPDH probe was used for normalization of the signals. (B) Receptor density (femtomoles per 106 cells) on spleen cells and thymocytes was assessed by measuring specific binding of [3H]CP55940 (1 nM) (see “Materials and methods”). (C) Effect of Cb1-specific antagonist SR141716 or Cb2-specific antagonist SR144528 on spontaneous or 2-AG–induced migration of spleen cells. Antagonists and 2-AG were placed in the wells as indicated under the figure.Y-axis shows percentage of migration from an input of 2 × 105 spleen cells. (D) Immunophenotyping of 2-AG–induced migrated spleen cells versus spontaneous spleen-migrated cells using flow cytometry.

Close Modal

or Create an Account

Close Modal
Close Modal